Riskpilot← Back to searchSign inGet full accessDiabeteskompassen AB
ABActiveOrg 5593437329Economic activity was not specified by tax authority · NACE 0000Est. 20210 employees
Revenue 2025
—
EBITDA margin
—
+21% vs 2024
Equity ratio
67.8%
Financial strength
Net profit 2025
SEK 150
-7% vs 2024
| Revenue | — | — |
| EBITDA | SEK -10K | +21% |
| Net profit | SEK 150 | -7% |
| Total assets | SEK 42K | +0% |
| Equity | SEK 29K | +1% |
| Employees | 0 | — |
Legal name
Diabeteskompassen AB
Org number
5593437329
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
1 november 2021
Share capital
SEK 36 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska skapa digitala verktyg som förenklar hantering av diabetes samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Staff expenses | — | — | — | — |
| EBITDA | −8 | −16 | −12 | −10 |
| Depreciation & amort. | — | — | — | — |
| EBIT | −8 | −16 | −12 | −10 |
| Net financials | — | — | — | — |
| Profit before tax | −8 | 0 | 0 | 0 |
| Tax | — | — | — | — |
| Net profit | −8 | 0 | 0 | 0 |
| Item | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 42 | 44 | 42 | 42 |
| Equity | 28 | 28 | 29 | 29 |
| Long-term debt | 14 | 0 | 14 | 14 |
| Short-term debt | — | 16 | 0 | — |
| Total debt | 14 | 16 | 14 | 14 |
EBITDA margin
-985000.0%
This company
15.8%
Market median
-6234277% vs market
20232025
Equity ratio
67.8%
This company
38.2%
Market median
+77% vs market
20232025
Return on equity
0.5%
This company
18.4%
Market median
-97% vs market
20232025
Net profit margin
15000.0%
This company
8.1%
Market median
+185085% vs market
20232025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20232025
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
20232025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-05-01 – 2023-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2021-11-01 – 2023-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2022 | |
| Former (4) | ||
| Board of Directors | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Consupedia AB
Diabeteskompassen AB Board members of Diabeteskompassen AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lina Anna Elisabeth Nordström | Board of Directors | 0 companies |
| Therése Lina Veronika Sjöholm | Deputy Board Member | 0 companies |
| Lars Hugo Viking Rillner | Deputy Board Member | 0 companies |
| Roberto Manuel Aurelio Åke Rufo Gonzalez | Board of Directors | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |
| Mikaela Jenni Berglund | Deputy Board Member | 0 companies |